Domestic pharmaceutical firms rushing to overseas markets

Published: 2003-07-10 06:59:00

Updated: 2003-07-10 06:59:00

Korea's leading pharmaceutical firms are rushing to foreign markets in an effort to avoid more cut-throat competition in the already saturated domestic market and expand their positions in the global market via set-up of foreign branch offices and increase in the number of export-oriented drugs.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK